COVID-19 vaccination, anticoagulation level and warfarin treatment.
作者信息
Mungmunpuntipantip Rujittika, Wiwanitkit Viroj
机构信息
Private Academic Consultant, Dimapur, India.
Dr DY Patil University, Pune, India.
出版信息
Blood Transfus. 2022 Nov;20(6):527. doi: 10.2450/2022.0067-22. Epub 2022 Jul 22.
Abstract
摘要
相似文献
1
COVID-19 vaccination, anticoagulation level and warfarin treatment.2019冠状病毒病疫苗接种、抗凝水平与华法林治疗
Blood Transfus. 2022 Nov;20(6):527. doi: 10.2450/2022.0067-22. Epub 2022 Jul 22.
2
Anti-SARS-CoV-2 vaccination does not influence anticoagulation levels in stable long-term warfarin treatment.抗 SARS-CoV-2 疫苗接种不会影响稳定长期华法林治疗中的抗凝水平。
Blood Transfus. 2022 Sep;20(5):433-436. doi: 10.2450/2022.0271-21. Epub 2022 Feb 28.
3
Warfarin anticoagulation in the Covid-19 pandemic: Telephone-based management at a regional hematology outpatient center in Joinville, Brazil.新冠疫情期间的华法林抗凝治疗：巴西茹安维尔地区血液学门诊中心的电话管理模式
Thromb Res. 2021 Sep;205:81-83. doi: 10.1016/j.thromres.2021.07.006. Epub 2021 Jul 9.
4
Outpatient management of chronic warfarin therapy at a pharmacist-run anticoagulation clinic during the COVID-19 pandemic.在 COVID-19 大流行期间，由药剂师管理的抗凝门诊对慢性华法林治疗进行的门诊管理。
J Thromb Thrombolysis. 2021 Oct;52(3):754-758. doi: 10.1007/s11239-021-02410-w. Epub 2021 Mar 6.
5
Lack of influence of SARS-CoV 2 vaccination on anticoagulation levels of patients on stable, long-term warfarin treatment.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）疫苗接种对接受稳定、长期华法林治疗患者的抗凝水平无影响。
Blood Transfus. 2022 Nov;20(6):528. doi: 10.2450/2022.0112-22. Epub 2022 Jul 22.
6
The changing face of anticoagulation management: an improving countenance.抗凝管理的变化面貌：日益改善的情形。
Pharmacotherapy. 2013 Nov;33(11):1133-5. doi: 10.1002/phar.1377.
7
Anti-PF4 antibody negative cerebral venous sinus thrombosis without thrombocytopenia following immunization with COVID-19 vaccine in an elderly non-comorbid Indian male, managed with conventional heparin-warfarin based anticoagulation.一名无合并症的老年印度男性在接种新冠疫苗后出现抗PF4抗体阴性的脑静脉窦血栓形成且无血小板减少症，采用基于普通肝素-华法林的抗凝治疗。
Diabetes Metab Syndr. 2021 Jul-Aug;15(4):102184. doi: 10.1016/j.dsx.2021.06.021. Epub 2021 Jun 24.
8
Need of more frequent International Normalized Ratio monitoring in elderly patients on long-term anticoagulant therapy after influenza vaccination.
Blood Coagul Fibrinolysis. 2002 Jun;13(4):297-300. doi: 10.1097/00001721-200206000-00004.
9
Curbside Coumadin Clinics Offer Testing During COVID-19 Crisis.
J Pharm Pract. 2020 Dec;33(6):734-735. doi: 10.1177/0897190020944054. Epub 2020 Aug 6.
10
Home anticoagulation monitoring is safe and effective.
Harv Heart Lett. 2000 Dec;11(4):4-5.
引用本文的文献
1
Interactions of warfarin with COVID-19 vaccine/drugs, monoclonal antibodies, and targeted anticancer agents from real-world data mining.基于真实世界数据挖掘的华法林与新冠疫苗/药物、单克隆抗体及靶向抗癌药物的相互作用
Front Pharmacol. 2024 Nov 29;15:1418997. doi: 10.3389/fphar.2024.1418997. eCollection 2024.
2
Lack of influence of SARS-CoV 2 vaccination on anticoagulation levels of patients on stable, long-term warfarin treatment.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）疫苗接种对接受稳定、长期华法林治疗患者的抗凝水平无影响。
Blood Transfus. 2022 Nov;20(6):528. doi: 10.2450/2022.0112-22. Epub 2022 Jul 22.
本文引用的文献
1
Anti-SARS-CoV-2 vaccination does not influence anticoagulation levels in stable long-term warfarin treatment.抗 SARS-CoV-2 疫苗接种不会影响稳定长期华法林治疗中的抗凝水平。
Blood Transfus. 2022 Sep;20(5):433-436. doi: 10.2450/2022.0271-21. Epub 2022 Feb 28.
2
CoaguChek® XS versus standard laboratory prothrombin time for anticoagulant monitoring in patients with antiphospholipid syndrome.抗磷脂综合征患者抗凝监测中 CoaguChek® XS 与标准实验室凝血酶原时间的比较。
Lupus. 2022 Apr;31(5):565-574. doi: 10.1177/09612033221086134. Epub 2022 Mar 10.
3
Expected Viscosity After COVID-19 Vaccination, Hyperviscosity and Previous COVID-19.新冠疫苗接种后的预期粘度、高粘度与既往新冠病毒感染
Clin Appl Thromb Hemost. 2021 Jan-Dec;27:10760296211020833. doi: 10.1177/10760296211020833.
Zotero 插件